Long-Term Benefits of Eccentric Cycling Exercise in Patients With Type 2 Diabetes Mellitus
Launched by UNIVERSITI SAINS MALAYSIA · Jul 30, 2025
Trial Information
Current as of November 10, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special type of cycling exercise called eccentric (ECC) cycling to see if it offers long-term benefits for men with type 2 diabetes. Unlike regular cycling, ECC cycling involves muscles working while lengthening, which might affect the body differently. The study will compare how moderate- and high-intensity ECC cycling impacts physical health, exercise ability, and overall quality of life, compared to regular (concentric) cycling. Researchers want to find out if ECC cycling could be a good option or addition to current exercise routines for managing type 2 diabetes.
Men between 30 and 60 years old with type 2 diabetes, who are not regularly active and have controlled blood sugar levels (HbA1C between 6-8%), may be eligible. Participants will start with two short sessions to get used to the cycling, then exercise twice a week for 10 weeks, either doing moderate- or high-intensity ECC cycling or moderate-intensity regular cycling. Before, during, and after the program, their health and fitness will be checked to see how the exercises affect them. People with serious health problems, those using insulin injections, or who have recent exercise experience won’t qualify. This study aims to find safe, effective ways to improve health and daily life for men managing type 2 diabetes.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male diagnosed with T2DM
- • Age 30 - 60 years old
- • Height ≥155cm (To ensure proper ergonomics, comfort and safety during cycling)
- • HbA1C level between 6-8%
- • No resistance exercise for ≤ 3 months before participating in the current study.
- • Physical inactivity (moderate to vigorous exercise ≤60 minutes weekly based on International Physical Activity Questionnaires-Short Form (IPAQ-SF))
- Exclusion Criteria:
- • Acute illness or any foot ulcer, diabetic ulcer, retinopathy, kidney, musculoskeletal, cardiovascular, or neurological disorder that could impair exercise performance or pose a risk to participants during exercise.
- • Insulin injection
About Universiti Sains Malaysia
Universiti Sains Malaysia (USM) is a leading research university in Malaysia, renowned for its commitment to advancing scientific knowledge and innovation in the healthcare sector. As a clinical trial sponsor, USM leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous research aimed at improving patient outcomes and addressing pressing health challenges. The university fosters collaboration among researchers, medical professionals, and industry partners, ensuring that its clinical trials are conducted with the highest ethical standards and scientific integrity. Through its dedication to excellence in research and education, USM plays a pivotal role in shaping the future of healthcare both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kepala Batas, Pulau Pinang, Malaysia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported